tiprankstipranks
GeneDx Holdings (WGS)
NASDAQ:WGS
US Market

GeneDx Holdings (WGS) Cash flow

394 Followers

GeneDx Holdings Cash Flow

WGS's free cash flow for Q1 2024 was $-16.86M. For the 2024 fiscal year, WGS's free cash flow was decreased by $144.95M and operating cash flow was $-16.41M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -166.72M$ -180.15M$ -319.15M$ -190.43M$ -93.13M
Investing Cash Flow
$ -38.02M$ -43.73M$ -141.33M$ -20.79M$ -31.97M
Financing Cash Flow
$ 138.70M$ 186.24M$ 197.31M$ 493.73M$ 129.06M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 309.69M$ 100.67M$ 138.30M$ 401.47M$ 118.96M
Income Tax Paid Supplemental Data
$ 1.48M$ 1.47M$ 1.24M$ 349.00K-
Interest Paid Supplemental Data
$ 3.13M$ 3.04M$ 1.93M$ 2.75M-
Issuance Of Capital Stock
$ 143.00M$ 143.00M$ 197.66M$ 350.00M$ 117.32M
Issuance Of Debt
$ -4.59M$ 42.95M$ -3.29M$ -13.47M$ 15.93M
Repayment Of Debt
$ -3.25M$ -5.60M$ -3.29M$ -13.47M$ -4.20M
Free Cash Flow
$ -125.06M$ -181.36M$ -326.31M$ -199.83M$ -125.10M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

GeneDx Holdings Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis